NYSE:CNCHealthcare
Centene (CNC): Assessing Valuation After Financial Guidance Withdrawal and Class-Action Lawsuits
Centene (CNC) has found itself in the spotlight after abruptly withdrawing its 2025 financial guidance, following an independent review that highlighted weaker market growth and less favorable morbidity trends than previously anticipated. That move triggered a wave of class-action lawsuits claiming the company misrepresented its financial health and key metrics like enrollment. For investors, this combination of legal claims and strategic uncertainty is forcing big questions about the...